PMID- 23449323 OWN - NLM STAT- MEDLINE DCOM- 20130827 LR - 20190720 IS - 1347-5215 (Electronic) IS - 0918-6158 (Linking) VI - 36 IP - 3 DP - 2013 TI - Mast cell stabilizing effect of (-)-Elema-1,3,11(13)-trien-12-ol and thujopsene from Thujopsis dolabrata is mediated by down-regulation of interleukin-4 secretion in antigen-induced RBL-2H3 cells. PG - 339-45 AB - Several isolated compounds from the wood part of Thujopsis dolabrata were evaluated for their inhibitory effects against antigen-induced mast cell degranulation and interleukin-4 (IL-4) secretion, as well as IL-4 mRNA and protein expression in immunoglobulin E (IgE)-sensitized RBL-2H3 cells. Among the five isolated compounds, (-)-elema-1,3,11(13)-trien-12-ol (1) and thujopsene (2) exhibited the potent inhibitory activity against mast cell degranulation measured by beta-hexosaminidase release with IC values of 27.4 microM and 25.1 microM, respectively. These compounds also inhibited the release of IL-4 (IC values of 7.0, 6.7 microM, respectively), IL-4 mRNA expression (IC values of 16.5, 7.2 microM, respectively) and IL-4 protein expression (IC values of 17.0, 9.6 microM, respectively) in antigen-induced IgE-sensitized RBL-2H3 cells. These results suggested that (-)-elema-1,3,11(13)-trien-12-ol (1) and thujopsene (2) effectively inhibits mast cell degranulation as well as IL-4 production, suggesting that these compounds from Thujopsis dolabrata can be used as candidates for IgE-mediated allergic disorders. FAU - Kim, Chul-Hee AU - Kim CH AD - Natural Products Research Institute, College of Pharmacy, Seoul National University. FAU - Lee, Taehun AU - Lee T FAU - Oh, Ikhoon AU - Oh I FAU - Nam, Kung-Woo AU - Nam KW FAU - Kim, Kyeong Ho AU - Kim KH FAU - Oh, Ki-Bong AU - Oh KB FAU - Shin, Jongheon AU - Shin J FAU - Mar, Woongchon AU - Mar W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Japan TA - Biol Pharm Bull JT - Biological & pharmaceutical bulletin JID - 9311984 RN - 0 (Sesquiterpenes) RN - 0 (elema-1,3,11(13)-trien-12-ol) RN - 207137-56-2 (Interleukin-4) RN - 37341-29-0 (Immunoglobulin E) RN - E116U47P7N (thujopsene) RN - EC 3.2.1.52 (beta-N-Acetylhexosaminidases) SB - IM MH - Animals MH - Cell Degranulation/drug effects MH - Cell Line, Tumor MH - Cupressus/*chemistry MH - Down-Regulation MH - Immunoglobulin E/*immunology MH - Interleukin-4/*antagonists & inhibitors/metabolism MH - Mast Cells/*drug effects/physiology MH - Rats MH - Sesquiterpenes/*pharmacology MH - beta-N-Acetylhexosaminidases/metabolism EDAT- 2013/03/02 06:00 MHDA- 2013/08/28 06:00 CRDT- 2013/03/02 06:00 PHST- 2013/03/02 06:00 [entrez] PHST- 2013/03/02 06:00 [pubmed] PHST- 2013/08/28 06:00 [medline] AID - DN/JST.JSTAGE/bpb/b12-00375 [pii] AID - 10.1248/bpb.b12-00375 [doi] PST - ppublish SO - Biol Pharm Bull. 2013;36(3):339-45. doi: 10.1248/bpb.b12-00375.